Drug Discovery

Antibodies
#Artificial intelligence (AI) #Biologics #Drug discovery #Therapeutic Antibodies #Webinar

Webinar: Meet the challenges of a shifting antibody discovery landscape

Antibody discovery is being reshaped by two forces: an explosion of novel formats and the growing role of AI across the DBTL loop. But most teams are still running antibody programs on software that hasn’t kept pace with science, leaving data siloed and relationships missing. In this webinar, hosted by… Read More

Webinar date:
Supported by Benching
#News

Illustration of a virus
#Biosafety testing #Drug discovery #Next generation sequencing #Webinar

Watch now: Overcome the bottlenecks in AVA testing

Biopharmaceutical manufacturers are under increasing pressure to deliver safe, reliable products at speed – yet adventitious viral agent (AVA) testing remains one of the most significant bottlenecks in the quality control process. In this on-demand webinar, ViruSure, a global leader in pathogen safety testing, shares how it… Read More

Webinar date:
Supported by Oxford Nanopore Technologies and ViruSure
#News

#Drug discovery #Surface plasmon resonance #Webinar

Watch on-demand: Scale your drug discovery programme by 12x

Surface plasmon resonance (SPR) has long been the gold standard for characterising molecular interactions in drug discovery, but throughput limitations have historically constrained its use in early-stage screening campaigns where large numbers of compounds or biologics candidates require rapid triage. The Carterra Vega changes that equation. … Read More

Webinar date:
Supported by Carterra
#News

#Biosafety testing #Drug discovery #Next generation sequencing #Webinar

Watch now: The first GMP-validated AVA test using Oxford Nanopore sequencing

Biopharmaceutical manufacturers are under increasing pressure to deliver safe, reliable products at speed – yet adventitious viral agent (AVA) testing remains one of the most significant bottlenecks in the quality control process. In this on-demand webinar, ViruSure, a global leader in pathogen safety testing, shares how it… Read More

Webinar date:
Supported by Oxford Nanopore Technologies and ViruSure
#News

Antibodies
#Artificial intelligence (AI) #Biologics #Drug discovery #Therapeutic Antibodies #Webinar

Webinar: Discover a modern data foundation for complex biologics

Antibody discovery is being reshaped by two forces: an explosion of novel formats and the growing role of AI across the DBTL loop. But most teams are still running antibody programs on software that hasn’t kept pace with science, leaving data siloed and relationships missing. In… Read More

Webinar date:
Supported by Benching
#News

Antibodies
#Antibodies #Biologics #Drug discovery #eBook

New eBook: B cell screening for antibody discovery

Thanks to their low toxicity and high specificity, therapeutic antibodies have enjoyed incredible market success across a range of disease categories. The global antibody discovery market, valued at $11.15 billion in 2025, is expected to surge to $35.35 billion by 2035. Experts predict this growth will… Read More

#News

eBook: B cell screening for antibody discovery
#Antibodies #Biologics #Drug discovery #eBook

B cell screening for antibody discovery

Download this exclusive eBook from Fluidic Sciences to learn more about: How the global antibody discovery market could evolve in the next 10 years How new technologies are improving efficiency and downstream success rates in antibody discovery Multiplexed rapid B cell screening and the future of antibody discovery… Read More

#eBooks #Resources

#AstraZeneca #Drug discovery #Europe #European Federation of Pharmaceutical Industries and Associations #FDA #Francis Crick Institute #Hypertension #Lung cancer #Mental health #Tropical disease #University of Dundee #Wellcome Trust

DDW Highlights: 26 May 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a report showed patients in Europe face barriers to medicine access. Elsewhere,… Read More

#Podcasts

Peptides
#Artificial intelligence (AI) #Drug discovery #Peptides #Webinar

Last chance to register: Discover cyclic peptide drug design

Cyclic peptides have a special power in the therapeutic space — they’re larger and more specific than small molecules, and more permeable and cost-effective than antibodies. These qualities enable them to conquer two of the biggest challenges in modern drug development: prosecuting flat intracellular protein-protein interactions (PPIs) and achieving oral… Read More

Webinar date:
Supported by BioDuro
#News

Cancer cells
#Cancer research #Drug discovery #eBook #Immunotherapy #Oncology

DDW eBook: Breakthroughs & expertise in cancer research

This eBook, sponsored by Sartorius, explores the latest developments in cancer research and why it matters, advances in immunotherapy, unlocking new frontiers in cancer research and ways that experts are driving the industry.  Download this exclusive eBook to learn more about:    Autotaxin… Read More

#News

#Drug discovery #Surface plasmon resonance #Webinar

Watch now: Efficient data processing and decision-making across large data sets

Surface plasmon resonance (SPR) has long been the gold standard for characterising molecular interactions in drug discovery, but throughput limitations have historically constrained its use in early-stage screening campaigns where large numbers of compounds or biologics candidates require rapid triage. The Carterra Vega changes that equation. … Read More

Webinar date:
Supported by Carterra
#News